Projects (2)

Current (2)

• 

  The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19

• 

  The QuickStart Study

Publications (103)

2023 (4)

• Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins.
  Rhee I, Spazzoli B, Stevens J, Hansa A, Spelman T, Pang G, Guiney M, Powell G, Choong P, Di Bella C
  ANZ J Surg. 2023 Feb; 93(3):577-84
• Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019.
  van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group.
  EClinicalMedicine. 2023 Feb; 56:101810
• Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study.
  Howell J, Van H, Pham MD, Sawhney R, Li F, Bhat P, Lubel J, Kemp W, Bloom S, Majumdar A, McCaughan GW, Hall S, Spelman T, Doyle JS, Hellard M, Visvanathan K, Thompson A, Drummer HE, Anderson D
  Liver Int. 2023 Jan; Epub ahead of print
• Individualised risk prediction for improved chronic wound management.
  Velickovic V, Spelman T, Clark M, Probst S, Armstrong DG, Steyerberg E
  Adv Wound Care. 2023 Jan; Epub ahead of print

2022 (6)

• Validation of novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study.
  Howell J, Traeger MW, Williams B, Layton C, Doyle JS, Latham N, Draper B, Bramwell F, Membrey D, McPherson M, Roney J, Stoové M, Thompson AJ, Hellard ME, Pedrana A
  Clin Liver Dis (Hoboken). 2022 Oct; 20(4):136-139
• Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial.
  Berger M, Li E, Rice S, Davey CG, Ratheesh A, Adams S, Jackson H, Hetrick S, Parker A, Spelman T, Kevin R, McGregor IS, McGorry P, Amminger GP
  J Clin Psychiatry. 2022 Aug; 83(5):21m14130
• Surgical resection of chest wall sarcomas: an analysis of survival and predictors of outcome at an Australian multidisciplinary sarcoma service.
  Thakur S, Choong E, Balasooriya A, Spelman T, Wright G, Choong P
  ANZ J Surg. 2022 Jul; 92(10):2613-2619
• 18F-FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial.
  Douglas A, Thursky K, Spelman T, Szer J, Bajel A, Harrison S, Tio SY, Bupha-Intr O, Tew M, Worth L, Teh B, Chee L, Ng A, Carney D, Khot A, Haeusler G, Yong M, Trubiano J, Chen S, Hicks R, Ritchie D, Slavin M
  Lancet Haematol. 2022 Jun; 9(8):e573-e584
• The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, Australia.
  Saul A, Scott N, Spelman T, Crabb BS, Hellard M
  BMC Infect Dis. 2022 Jun; 22(1):514
• Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.
  Marukutira T, Moore KP, Hellard M, Richmond J, Turner K, Pedrana AE, Melody S, Johnston FH, Owen L, Van Den Boom W, Scott N, Thompson A, Iser D, Spelman T, Veitch M, Stoové MA, Doyle J
  BMJ Open. 2022 Mar; 12(3):e056120

2021 (6)

• Impact of Image Reconstruction Parameters on Abdominal Aortic Calcification Measurement Using Abdominal Computed Tomography.
  Abdelganne L, Song F, Oliver J, Galea M, Chen X, McGill J, Spelman T, Lim RP, Kutaiba N
  J Comput Assist Tomogr. 2021 Sep; 45(6):849-855
• Treatment of tungiasis using a tea tree oil-based gel formulation: protocol for a randomised controlled proof-of-principle trial.
  Abrha S, Christenson JK, McEwen J, Tesfaye W, Vaz Nery S, Chang AY, Spelman T, Kosari S, Kigen G, Carroll S, Heukelbach J, Feldmeier H, Bartholomaeus A, Daniel M, Peterson GM, Thomas J
  BMJ Open. 2021 Jul; 11(7):e047380
• The introduction of a mandatory mask policy was associated with significantly reduced COVID-19 cases in a major metropolitan city.
  Scott N, Saul A, Spelman T, Stoove M, Pedrana A, Saeri A, Grundy E, Smith L, Toole M, McIntyre CR, Crabb BS, Hellard M
  PLoS One. 2021 Jul; 16(7):e0253510
• Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs.
  Goutzamanis S, Spelman T, Harney B, Dietze P, Stoové M, Higgs P, Thompson A, Doyle JS, Hellard M; Treatment, Prevention Study group.
  J Viral Hepat. 2021 Apr; 28(7):1068-1077
• Multicentre stepped-wedge cluster randomised controlled trial of an antimicrobial stewardship programme in residential aged care: protocol for the START trial.
  Jokanovic N, Haines T, Cheng AC, Holt KE, Hilmer SN, Jeon YH, Stewardson AJ, Stuart RL, Spelman T, Peel TN, Peleg AY; START Trial Group
  BMJ Open. 2021 Mar; 11(3):e046142
• Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.
  Kalincik T, Diouf I, Sharmin S, Malpas C, Spelman T, Horakova D, Havrdova EK, Trojano M, Izquierdo G, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Jokubaitis V, van der Walt A, Grand'Maison F, Sola P, Ferraro D, Shaygannejad V, Alroughani R, Hupperts R, Terzi M, Boz C, Lechner-Scott J, Pucci E, Van Pesch V, Granella F, Bergamaschi R, Spitaleri D, Slee M, Vucic S, Ampapa R, McCombe P, Ramo-Tello C, Prevost J, Olascoaga J, Cristiano E, Barnett M, Saladino ML, Sanchez-Menoyo JL, Hodgkinson S, Rozsa C, Hughes S, Moore F, Shaw C, Butler E, Skibina O, Gray O, Kermode A, Csepany T, Singhal B, Shuey N, Piroska I, Taylor B, Simo M, Sirbu CA, Sas A, Butzkueven H; MSBase Study group
  Neurology. 2021 Feb; 96(5):e783-e797

2020 (7)

• Estimates of the global reduction in liver disease-related mortality with increased coffee consumption: an analysis of the Global Burden of Disease Dataset.
  Gow P, Spelman T, Gardner S, Hellard M, Howell J
  Aliment Pharmacol Ther. 2020 Aug; 52(7):1195-1203
• Early surgical complications of total hip arthroplasty related to surgical approach.
  Hoskins W, Dowsey MM, Spelman T, Choong PFM
  ANZ J Surg. 2020 Jul; 90(10):2050-2055
• Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes.
  Allard NL, MacLachlan JH, Dev A, Dwyer J, Srivatsa G, Spelman T, Thompson AJ, Cowie BC
  BMC Gastroenterol. 2020 May; 20(1):140
• Gaps in the HIV diagnosis and care cascade for migrants in Australia, 2013-2017: A cross-sectional study.
  Marukutira T, Gray RT, Douglass C, El-Hayek C, Moreira C, Asselin J, Donovan B, Vickers T, Spelman T, Crowe S, Guy R, Stoové M, Hellard M
  PLoS Med. 2020 Mar; 17(3):e1003044
• The effects of sublingual nitroglycerin administration in coronary computed tomography angiography.
  Kutaiba N, Lukies M, Galea M, Begbie M, Smith G, Kearney L, Spelman T, Lim RP
  Clin Imaging. 2020 Feb; 60(2):194-199
• Trends in late and advanced HIV diagnoses among migrants in Australia; implications for progress on Fast-Track targets: A retrospective observational study.
  Marukutira T, Gunaratnam P, Douglass C, Jamil MS, McGregor S, Guy R, Gray RT, Spelman T, Horyniak D, Higgins N, Giele C, Crowe SM, Stoové M, Hellard M
  Medicine. 2020 Feb; 99(8):e19289
• The prognostic significance of attenuated psychotic symptoms in help-seeking youth.
  Hazan H, Spelman T, Amminger GP, Hickie I, McGorry PD, Phillips LJ, Purcell R, Wood SJ, Yung AR, Nelson B
  Schizophr Res. 2020 Jan; 215:277-83

2019 (4)

• Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study.
  Einsiedel L, Pham H, Au V, Hatami S, Wilson K, Spelman T, Jersmann H
  ERJ Open Res. 2019 Oct; 5(4):00001-2019
• Clinical outcomes of a cohort of migrants and citizens living with human immunodeficiency virus in Botswana: implications for Joint United Nation Program on HIV and AIDS 90-90-90 targets.
  Marukutira T, Yin D, Cressman L, Kariuki R, Malone B, Spelman T, Mawandia S, Ledikwe JH, Semo BW, Crowe S, Stoove M, Hellard M, Dickinson D
  Medicine. 2019 Jun; 98(23):e15994
• Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
  Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, Tee BK, Fairley CK, Chang CC, Armishaw J, Vujovic O, Penn M, Cundill P, Forgan-Smith G, Gall J, Pickett C, Lal L, Mak A, Spelman TD, Nguyen L, Murphy DA, Ryan KE, El-Hayek C, West M, Ruth S, Batrouney C, Lockwood JT, Hoy JF, Hellard ME, Stoové MA, Wright EJ; PrEPX Study Team
  JAMA. 2019 Apr; 321(14):1380-1390
• Injection drug network characteristics as a predictor of injection behaviour.
  Spelman T, Sacks-Davis R, Dietze P, Higgs P, Hellard M
  Epidemiol Infect. 2019 Jan; 147:e173

2018 (6)

• Description of social contacts among student cases of pandemic influenza during the containment phase, Melbourne, Australia, 2009.
  Caroline van Gemert, Emma S McBryde, Isabel Bergeri, Rachel Sacks-Davis, Hassan Vally, Tim Spelman, Brett Sutton, Margaret Hellard
  Western Pac Surveill Response J. 2018 Oct; 9(5 Suppl 1):27-34
• Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model.
  Veličković VM, Borisenko O, Svensson M, Spelman T, Siebert U
  PLoS One. 2018 Sep; 13(9):e0204643
• Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis.
  Min M, Spelman T, Lugaresi A, Boz C, Spitaleri D, Pucci E, Grand'Maison F, Granella F, Izquierdo G, Butzkueven H, Sanchez-Menoyo JL, Barnett M, Girard M, Trojano M, Grammond P, Duquette P, Sola P, Alroughani R, Hupperts R, Vucic S, Kalincik T, Van Pesch V, Lechner-Scott J
  Mult Scler. 2018 Sep; 24(12):1569-1577
• Treatment of scabies using a tea tree oil-based gel formulation in Australian Aboriginal children: protocol for a randomised controlled trial.
  Thomas J, Davey R, Peterson GM, Carson C, Walton SF, Spelman T, Calma T, Dettwiller P, Tobin J, McMillan F, Collis P, Naunton M, Kosari S, Christenson JK, Bartholomaeus A, McEwen J, Fitzpatrick P, Baby KE
  BMJ Open. 2018 May; 8(5):e018507
• Patient characteristics, procedural and safety outcomes of bariatric surgery in England: a retrospective Cohort Study-2006-2012.
  Sun S, Borisenko O, Spelman T, Ahmed AR
  Obes Surg. 2018 Apr; 28(4):1098-1108
• Are people who inject drugs frequent users of emergency department services? A cohort study (2008-2013).
  Nambiar D, Spelman T, Stoové M, Dietze P
  Subst Use Misuse. 2018 Feb; 53(3):457-465

2017 (5)

• Impaired placental autophagy in placental malaria.
  Dimasuay KG, Gong L, Rosario F, McBryde E, Spelman T, Glazier J, Rogerson SJ, Beeson JG, Jansson T, Devenish RJ, Boeuf P
  PLoS One. 2017 Nov; 12(11):e0187291
• Infection is an independent predictor of death in diffuse large B cell lymphoma.
  Dendle C, Gilbertson M, Spelman T, Stuart RL, Korman TM, Thursky K, Opat S, McQuilten Z
  Sc Rep. 2017 Jun; 7(1):4395
• Upper extremity non-contrast magnetic resonance venography (MRV) compared to contrast enhanced MRV and ultrasound.
  Lim RP, Hornsey E, Ranatunga D, Hao H, Smith J, Spelman T, Chuen J, Goodwin M
  Clin Imaging. 2017 Jun; 45:51-57
• No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.
  Mota TM, Rasmussen TA, Rhodes A, Tennakoon S, Dantanarayana A, Wightman F, Hagenauer M, Roney J, Spelman T, Purcell DF, McMahon J, Hoy JF, Prince HM, Elliott JH, Lewin SR
  AIDS. 2017 May; 31(8):1137-1141
• Multidetector (64+) Computed Tomography Angiography of the Lower Limb in Symptomatic Peripheral Arterial Disease: Assessment of Image Quality and Accuracy in a Tertiary Care Setting.
  Lim JC, Ranatunga D, Owen A, Spelman T, Galea M, Chuen J, Lim RP
  J Comput Assist Tomogr. 2017 Mar; 41(2):327-333

2016 (10)

• Quantifying adaptive and innate immune responses in HIV-infected participants using a novel high throughput assay.
  Yong MK, Cameron PU, Spelman T, Elliott JH, Fairley CK, Boyle J, Miyamasu M, Lewin SR
  PLoS One. 2016 Dec; 11(12):e0166549
• A 'test and treat' prevention strategy in Australia requires innovative HIV testing models: a cohort study of repeat testing among 'high-risk' men who have sex with men.
  Wilkinson AL, El-Hayek C, Spelman T, Fairley CK, Leslie D, McBryde ES, Hellard M, Stoové M
  Sex Transm Infect. 2016 Sep; 92(6):464-466
• Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.
  Yong YK, Shankar EM, Westhorpe CL, Maisa A, Spelman T, Kamarulzaman A, Crowe SM, Lewin SR
  Medicine (Baltimore). 2016 Aug; 95(31):e4477
• Risk factors for unstructured treatment interruptions and association with survival in low to middle income countries.
  McMahon JH, Spelman T, Ford N, Greig J, Mesic A, Ssonko C, Casas EC, O'Brien DP
  AIDS Res Ther. 2016 Jul; 13(4):25
• Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.
  Doyle JS, Grebely J, Spelman T, Alavi M, Matthews GV, Thompson AJ, Dore GJ, Hellard ME; ATAHC Study Group.
  PLoS One. 2016 Jun; 11(6):e0150655
• Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.
  Yong YK, Shankar EM, Solomon A, Spelman T, Fairley CK, Elliott J, Hoy J, Cameron P, Kamarulzaman A, Lewin SR
  AIDS. 2016 Jun; 30(14):2159-2168
• Comparison of oncological and health related quality of life (HRQOL) outcomes between open (ORP) and robotic-assisted radical prostatectomy (RARP) for localized prostate cancer - findings from the population-based Victorian Prostate Cancer Registry (PCR).
  Ong WL, Evans SM, Spelman T, Kearns PA, Murphy DG, Millar JL
  BJU Int. 2016 Feb; 118(4):563-569
• Therapeutic Potential of Tea Tree Oil for Scabies.
  Thomas J, Carson CF, Peterson GM, Walton SF, Hammer K, Naunton M, Davey R, Spelman T, Dettwiller P, Baby KE, Kyle G, Cooper G
  Am J Trop Med Hyg. 2016 Jan; 94(2):258-266
• Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings.
  O'Brien D, Spelman T, Greig J, McMahon J, Ssonko C, Casas E, Mesic A, Du Cros P, Ford N
  J Int AIDS Soc. 2016 Jan; 19(1):20665
• Predictors and rate of adjuvant radiation therapy following radical prostatectomy: A report from the Prostate Cancer Registry.
  Daniels CP, Millar JL, Spelman T, Sengupta S, Evans SM
  J Med Imaging Radiat Oncol. 2016 Jan; 60(2):247-254

2015 (13)

• 2015 - a seminal year for HIV biomedical prevention.
  Zablotska IB, Spelman T, Grulich A
  J Int AIDS Soc. 2015 Dec; 18(1):20814
• Which factors influence the activity levels of individuals with traumatic brain injury when they are first discharged home from hospital?
  Hamilton M, Williams G, Bryant A, Clark R, Spelman T
  Brain Inj. 2015 Sep; 29(13-14):1572-1580
• Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.
  Doyle JS, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, Matthews G, Rice TM, Morris MD, McGovern BH, Kim AY, Bruneau J, Lloyd AR, Page K, Manns MP, Hellard ME, Dore GJ and the InC3 Study Group.
  J Viral Hepat. 2015 Jun; 22(12):1020-1023
• Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.
  Winter RJ, Stoové M, Degenhardt L, Hellard ME, Spelman T, Jenkinson R, McCarthy DR, Kinner SA
  Drug Alcohol Depend. 2015 Jun; 153:43-49
• Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
  Alavi M, Spelman T, Matthews GV, Haber PS, Day C, van Beek I, Walsh N, Yeung B, Bruneau J, Petoumenos K, Dolan K, Kaldor JM, Dore GJ, Hellard M, Grebely J; ATAHC Study Group
  Int J Drug Policy. 2015 May; 26(10):976-983
• Agreement and mortality prediction in high-resolution CT of diffuse fibrotic lung disease.
  Siemienowicz ML, Kruger SJ, Goh NS, Dobson JE, Spelman TD, Fabiny RP
  J Med Imaging Radiat Oncol. 2015 May; 59(5):555-563
• Hepatitis C virus reinfection and spontaneous clearance of reinfection - the InC3 study.
  Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M; InC3 study group
  J Infect Dis. 2015 Apr; 212(9):1407-19
• "Seek, Test, Treat" Lessons from Australia: A Study of HIV testing patterns from a cohort of men who have sex with men.
  Wilkinson AL, El-Hayek C, Spelman T, Fairley C, Leslie D, McBryde E, Hellard M, Stoové M
  J Acquir Immune Defic Syndr. 2015 Mar; 69(4):460-465
• A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.
  Spelman T, Morris MD, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J; International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3 Study).
  J Epidemiol Community Health. 2015 Mar; 69(8):745-752
• An analysis of the thromboembolic outcomes of 2472 splenectomized individuals.
  Dendle C, Spelman T, Sundararajan V, Chunilal S, Woolley I
  Blood. 2015 Mar; 125(10):1681-1682
• Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B.
  Giles M, Visvanathan K, Lewin S, Bowden S, Locarnini S, Spelman T, Sasadeusz J
  Gut. 2015 Mar; 64(11):1810-1815
• Time of Day and Day of Week Trends in EMS Demand.
  Cantwell K, Morgans A, Smith K, Livingston M, Spelman T, Dietze P
  Prehosp Emerg Care. 2015 Feb; 19(3):425-431
• The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte/macrophage activation in treated HIV-infected individuals.
  Rajasuriar R, Kong Y, Nadarajah R, Abdullah N, Spelman T, Yuhana M, Ponampalavanar S, Kamarulzaman A, Lewin SR
  J Transl Med. 2015 Jan; 13(1):30

2014 (8)

• A randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetes.
  Elkassaby S, Harrison LC, Mazzitelli N, Wentworth JM, Colman PG, Spelman T, Fourlanos S
  Diabetes Res Clin Pract. 2014 Dec; 106(3):576-582
• Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay.
  Cheah AL, Spelman T, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC
  Epidemiol Infect. 2014 Dec; 142(12):2667-2671
• C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals.
  Westhorpe CL, Schneider HG, Dunne M, Middleton T, Sundararajan V, Spelman T, Carter V, Crowe SM, Dart A, Mijch A, Kotsanas D, Woolley I
  Sex Health. 2014 Dec; 11(6):580-582
• Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy.
  Elliott JH, Wightman F, Solomon A, Ghneim K, Ahlers J, Cameron MJ, Smith MZ, Spelman T, McMahon J, Velayudham P, Brown G, Roney J, Watson J, Prince MH, Hoy JF, Chomont N, Fromentin R, Procopio FA, Zeidan J, Palmer S, Odevall L, Johnstone RW, Martin BP, Sinclair E, Deeks SG, Hazuda DJ, Cameron PU, Sékaly RP, Lewin SR
  PLoS Pathog. 2014 Oct; 10(10):e1004473
• Lytic Gene Expression Is Frequent in HSV-1 Latent Infection and Correlates with the Engagement of a Cell-Intrinsic Transcriptional Response.
  Ma JZ, Russell TA, Spelman T, Carbone FR, Tscharke DC
  PLoS Pathog. 2014 Jul; 10(7):e1004237
• Lipopolysaccharide, immune activation and liver abnormalities in HIV-HBV co-infected individuals on HBV-active combination antiretroviral therapy.
  Crane M, Avihingsanon A, Rajasuriar R, Velayudham P, Iser D, Solomon A, Sebolao B, Tran A, Spelman T, Matthews G, Cameron P, Tangkijvanich P, Dore GJ, Ruxrungtham K, Lewin SR
  J Infect Dis. 2014 Feb; 210(5):745-751
• Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals.
  Westhorpe CL, Maisa A, Spelman T, Hoy JF, Dewar EM, Karapanagiotidis S, Hearps AC, Cheng WJ, Trevillyan J, Lewin SR, Sviridov D, Elliott JH, Jaworowski A, Dart AM, Crowe SM
  Immunol Cell Biol. 2014 Jan; 92(2):133-138
• Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
  Aspinall EJ, Weir A, Sacks-Davis R, Spelman T, Grebely J, Higgs P, Hutchinson SJ, Hellard ME
  Int J Drug Policy. 2014 Jan; 25(1):179-182

2013 (8)

• High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.
  Sacks-Davis R, Aitken CK, Higgs P, Spelman T, Pedrana AE, Bowden S, Bharadwaj M, Nivarthi UK, Suppiah V, George J, Grebely J, Drummer HE, Hellard M
  PLoS One. 2013 Nov; 8(11):e80216
• Predictors of Raised Viral Load during Antiretroviral Therapy in Patients with and without Prior Antiretroviral Use: A Cross-Sectional Study.
  Greig JE, du Cros PA, Mills C, Ugwoeruchukwu W, Etsetowaghan A, Grillo A, Tayo-Adetoro A, Omiyale K, Spelman T, O'Brien DP
  PLoS One. 2013 Aug; 8(8):e71407
• Chemokine levels and chemokine receptor expression in blood and the CSF of HIV-infected patients with cryptococcal meningitis and C-IRIS.
  Chang CC, Omarjee S, Lim A, Spelman T, Gosnell BI, Carr WH, Elliott JH, Moosa MY, Ndung'u T, French MA, Lewin SR
  J Infect Dis. 2013 Aug; 208(10):1604-1612
• Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings.
  Marshall CS, Curtis AJ, Spelman T, O'Brien DP, Greig J, Shanks L, du Cros P, Casas EC, da Fonseca MS, Athan E, Elliott JH
  PLoS One. 2013 Jul; 8(7):e68445
• Cryptococcosis-IRIS is associated with lower Cryptococcus-specific IFN-gamma responses before antiretroviral therapy but not higher T-cell responses during therapy.
  Chang CC, Lim A, Omarjee S, Levitz SM, Gosnell BI, Spelman T, Elliott JH, Carr WH, Moosa MY, Ndung'u T, Lewin SR, French MA
  J Infect Dis. 2013 Jun; 208(6):898-906
• Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
  Cheah AL, Spelman T, Liew D, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC
  Clin Microbiol Infect. 2013 Apr; 19(4):E181-E189
• Clinical and mycological predictors of cryptococcosis-associated Immune reconstitution inflammatory syndrome (C-IRIS).
  Chang CC, Dorasamy AA, Gosnell BI, Elliott JH, Spelman T, Omarjee S, Naranbhai V, Coovadia Y, Ndung'u T, Moosa MY, Lewin SR, French MA
  AIDS. 2013 Mar; 27(13):2089-2099
• Inhibition of telomerase activity by HIV Nucleos(t)ide Reverse Transcriptase Inhibitors: a potential factor contributing to HIV-associated accelerated ageing.
  Leeansyah E, Cameron PU, Solomon A, Tennakoon S, Pushparaj Velayudham, Maelenn Gouillou, Tim Spelman, Anna Hearps, Christopher Fairley, De Villiers Smit, Anna B Pierce, Jude Armishaw, Suzanne M Crowe, David A Cooper, Kersten K Koelsch, Jun-Ping Liu, John Chuah, Lewin SR
  J Infect Dis. 2013 Jan; 207(7):1157-65

2012 (9)

• Incidence of WHO Stage 3 and 4 Conditions following Initiation of Anti-Retroviral Therapy in Resource Limited Settings.
  Curtis AJ, Marshall CS, Spelman T, Greig J, Elliot JH, Shanks L, Du Cros P, Casas EC, Da Fonseca MS, O'Brien DP
  PLoS One. 2012 Dec; 7(12):e52019
• CRF01_AE dominates the HIV-1 epidemic in Indonesia.
  Merati TP, Ryan CE, Spelmen T, Wirawan DN, Bakta IM, Otto B, Oelrichs RB, Crowe SM
  Sex Health. 2012 Sep; 9(5):414-421
• Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individuals.
  Li S, Roberts S, Plebanski M, Gouillou M, Spelman T, Latour P, Jackson D, Brown L, Sparrow R, Prince M, Hart D, Loveland BE, Gowans EJ
  PLoS One. 2012 Aug; 7(8):e39368
• Splenectomy sequelae: an analysis of infectious outcomes among adults in Victoria.
  Dendle C, Sundararajan V, Spelman T, Jolley D, Woolley I
  Med J Aust. 2012 May; 196(9):582-586
• Prevalence survey of dermatological conditions in mountainous north India.
  Grills N, Grills C, Spelman T, Stoové M, Hellard M, El-Hayek C, Singh R
  Int J Dermatol. 2012 May; 51(5):579-587
• Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa.
  Greig J, O'Brien DP, Ford N, Spelman T, Sabapathy K, Shanks L
  JAIDS. 2012 Apr; 59(5):e92-e98
• Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
  Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D
  Clin Microbiol Infect. 2012 Apr; 18(4):388-394
• Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
  Ananda-Rajah MR, Grigg A, Downey MT, Bajel A, Spelman T, Cheng A, Thursky KT, Vincent J, Slavin MA
  Haematologica. 2012 Mar; 97(3):459-463
• The role of SNPs in the alpha-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART.
  Rajasuriar R, Booth DR, Gouillou M, Spelman T, James I, Solomon A, Chua K, Stewart G, Deeks S, Bangsberg DR, Muzoora C, Cameron PU, Hunt P, Martin J, Lewin SR
  Genes Immun. 2012 Jan; 13(1):83-93

2011 (8)

• SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.
  Price CF, Tyssen D, Sonza S, Davie A, Evans S, Lewis GR, Xia S, Spelman T, Hodsman P, Moench TR, Humberstone A, Paull JR, Tachedjian G
  PLoS One. 2011 Sep; 6(9):e24095
• Sexual history taking and sexually transmissible infection screening practices among men who have sex with men: a survey of Victorian general practitioners.
  Barber B, Hellard M, Jenkinson R, Spelman T, Stoové M
  Sex Health. 2011 Sep; 8(3):349-354
• Risk factors for HIV seroconversion in men who have sex with men in Victoria, Australia: results from a sentinel surveillance system.
  Guy RJ, Spelman T, Stoové M, El-Hayek C, Goller J, Fairley CK, Leslie D, Tee B, Roth N, Grulich AE, Hellard ME
  Sex Health. 2011 Sep; 8(3):319-329
• Intrahousehold transmission of pandemic (H1N1) 2009 virus, Victoria, Australia.
  van Gemert C, Hellard M, McBryde ES, Fielding J, Spelman T, Higgins N, Lester R, Vally H, Bergeri I
  Emerg Infect Dis. 2011 Sep; 17(9):1599-1607
• Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.
  Rajasuriar R, Gouillou M, Spelman T, Read T, Hoy J, Law M, Cameron PU, Petoumenos K, Lewin SR
  PLoS One. 2011 Jun; 6(6):e20713
• Impact evaluation of a youth sexually transmissible infection awareness campaign using routinely collected data sources.
  Gold J, Goller J, Hellard M, Lim MS, Hocking J, Fairley CK, Spelman T, McNamee K, Clift P, Guy R
  Sex Health. 2011 Jun; 8(2):234-241
• Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
  Ananda-Rajah MR, Cheng A, Morrissey CO, Spelman T, Dooley M, Neville AM, Slavin M
  Antimicrob Agents Chemother. 2011 May; 55(5):1953-1960
• Determining the impact of text messaging for sexual health promotion to young people.
  Gold J, Lim MS, Hocking JS, Keogh LA, Spelman T, Hellard ME
  Sex Transm Dis. 2011 Apr; 38(4):247-252

2010 (6)

• Critical evaluation: are patients after splenectomy at risk of infections?
  Cheng AC, Spelman T, Jones P, Spelman D
  ANZ J Surgery. 2010 Nov; 80(11):844-845
• Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor alpha and microbial translocation.
  Rajasuriar R, Booth D, Solomon A, Chua K, Spelman T, Gouillou M, Schlub TE, Davenport M, Crowe S, Elliott J, Hoy J, Fairley C, Stewart G, Cameron P, Lewin SR
  J Infect Dis. 2010 Oct; 202(8):1254-1264
• Does the frequency of HIV and STI testing among men who have sex with men in primary care adhere with Australian guidelines?
  Guy R, Goller JL, Spelman T, El-Hayek C, Gold J, Lim M, Leslie D, Tee BK, Roth N, Anderson J, Fairley CK, Kaldor J, Hellard M
  Sex Transm Infect. 2010 Oct; 86(5):371-376
• HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.
  Audsley J, Littlejohn M, Yuen L, Sasadeusz J, Ayres A, Desmond C, Spelman T, Lau G, Matthews GV, Avihingsanon A, Seaberg E, Philp F, Saulynas M, Ruxrungtham K, Dore GJ, Locarnini SA, Thio CL, Lewin SR, Revill PARuxrungtham, Gregory J Dore, Stephen A Locarnini, Chloe L Thio, Sharon R Lewin, Peter A Revill
  Virology. 2010 Sep; 405(2):539-547
• Early adherence to antiretroviral medication as a predictor of long-term HIV virological suppression: five-year follow up of an observational cohort.
  Ford N, Darder M, Spelman T, Maclean E, Mills E, Boulle A
  PLoS One. 2010 May; 5(5):e10460
• Surveillance of drug use among young people attending a music festival in Australia, 2005-2008.
  Lim MS, Sacks-Davis R, Aitken CK, Hocking JS, Hellard ME
  Drug Alcohol Rev. 2010 Mar; 29(2):150-156

2009 (1)

• Enhancement of human immunodeficiency virus type 1 replication is not intrinsic to all polyanion-based microbicides.
  Sonza S, Johnson A, Tyssen D, Spelman T, Lewis GR, Paull JR, Tachedjian G
  Antimicrob Agents Chemother. 2009 Aug; 53(8):3565-3568

2008 (1)

• Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications.
  Guy R, Devadason D, Lim M, Higgins N, Pedrana A, Gibson K, Lewis J, Spelman T, White B, Kaldor J, Hellard M
  Commun Dis Intell. 2008 Jun; 32(2):250-256

2004 (1)

• Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit.
  Marshall C, Wolfe R, Kossmann T, Wesselingh S, Harrington G, Spelman D
  J Hosp Infect. 2004 Jul; 57(3):245-252

News Articles (4)

2021 (1)

• World-first study shows effectiveness of masks in preventing COVID transmission

2017 (1)

• U=U addressing HIV stigma

2016 (2)

• NHMRC grants for Burnet researchers
• NHMRC grants for Burnet research